PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

COMPANY UPDATE – AUDITED FY 2018

2

Agenda

1 COMPANY OVERVIEW

BUSINESS OVERVIEW

FINANCIAL PERFORMANCE – FY 2018 (AUDITED)

APPENDIX

2

3

4

COMPANY OVERVIEW

4

Preserving Indonesian heritage for more than 67 years andkeep maintaining the quality of the products

1951Founded by Mrs.Rakhmat Sulistio in1940 with the firstformula, Jamu TolakAngin. In 1951, thecompany SIDOMUNCUL wasestablished

1984Modern production facilitywas installed In order toaccommodate thegrowing market demand.The production facilitywas in LingkunganIndustri Kecil, Semarang.

2000The inauguration ofnew factory in an areaof 30ha, located inKlepu, with CPOB &CPOTB standard andalso equipped with ISOstandard facilities.

2013Conducted initial publicoffering with the issue priceof Rp580 per share, tickercode: SIDO.

2014Acquisition of PT BerlicoMulia Farma, expandingSido Muncul’s businessin the pharmaceuticalindustry

2017Commercializationthe new extractionfacilities of PTSemarang HerbalIndo Plant, withincrement ofextraction capacityand more efficient.

2018Finalization of thenew herbal liquidproduction facilities,more modern,integrated, withcapacity up to100mn sachets permonth

2004Marketing the first non-herbal product “KukuBima Ener-G!” originalflavor and has launchedvarious flavors to date.

5Gerry Mustika

Independent Director

Result of EGMS & AGMS – 2018

BOARD OF COMMISIONERS

Jonatha Sofjan HidajatPresident Commissioner

Sigit Hartojo Hadi SantosoCommissioner

Johan HidayatCommissioner

Ronnie BeharIndependent Commissioner

Eric MarnandusIndependent Commissioner

BOARD OF DIRECTORS

David HidayatPresident Director

Irwan HidayatDirector

LeonardIndependent Director

The EGMS conducted on January 31, 2018approved the appointment of Ronnie Beharand Eric Marnandus as IndependentCommissioners.

The AGMS conducted on May 30, 2018concluded:Declared cash dividend of Rp29 per share

or 80.85% of the Company’s 2017 net profitApproved the appointment of Jonatha

Sofjan Hidayat as President CommissionerApproved the appointment of David

Hidayat as President DirectorApproved the appointment of Leonard dan

Gerry Mustika as Independent Director

BUSINESS OVERVIEW

7

Product innovation, technology, also supported by strongdistribution network become the business driver of SidoMuncul

Vision :

To become a leading herbalmedicine, health food & drinks,

and herbal ingredientprocessing company which can

benefit the community andenvironment

1. PRODUCT QUALITYThe largest producer of

herbal medicine in Indonesiawith innovative products andstrong brand awareness in

the market.

2. PROCESSINGTECHNOLOGY

Production facilities withmodern and automation

technology

3. DISTRIBUTIONNETWORK

Strong distribution networkspread throughout Indonesiaand has penetrated overseas

market

4. SOCIALRESPONSIBILITY

Sustainable business for thebenefit of the company,

society, and environment

8

Product portfolio with featured products in each segments,has become TOP OF MIND in Indonesian consumers

Herbal Medicine PharmaceuticalFood & Beverages

1

9

New liquid herbal medicine production facility with moderntechnology and computerized

• Production capacityup to 100 mnsachets per monthfor all variants ofliquid herbalmedicine

• Modern, automatic,and more accurateto prevent mistakesin the productionprocess and humanerror

• Integratedproduction systemand more efficient

2

10

Strong distribution network spread throughout Indonesia

Sido Muncul PlantSemarang

Berlico PlantYogyakarta

Sub-distributors

SUMATERA: 24

JABODETABEK& JABAR: 16

KALIMANTAN: 9

JATENG: 12

SULAWESI: 13

JATIM: 14

EASTERN INDONESIA: 18

BALI & NT: 16

Muncul Mekar has 122 sub-distributors in general trade and cooperates with modernretail and pharmaceutical wholesalers, also online stores in Indonesia.

3

11

Developing potential of export market

• Established MunculNigeria Limited

• Acquired certificate ofproduct registrationfor KBE

• Established branchoffice

• Pipelining in GTand MT for TA

• Available at 7/11,Mercury Drugs,South-Star Drugs,Watsons

Sido Muncul products have existed in several countries and to expand the export market,the company has been established branch office in Philippine (2017) and subsidiary inNigeria (2018)

3

12

Giving back to the community as part of the sustainability4

13

Received various awards related to branding, products,business, and also environment

FINANCIAL PERFORMANCE – FY 2018 (AUDITED)

15

Financial performance – FY 2018

Net sales increased by 7.4% in FY18 with all business segment grew positivecompared to last year.

Gross profit was higher by 20%, coming from higher revenue, higher recovery ratefrom SHI’s extraction facility, and lower royalty payment. Gross margin improvedfrom 46.0% to 51.5%.

A&P cost was align within our budget at 10% of sales, resulting growth inoperating profit by 28.8%.

FY 2018, SIDO booked IDR 663,8bn ore grew by 24% on NPAT with higher profit margincompared to last year

(Rp Billion – Audited)

2,573.8

2,763.3

2017

2018

SALES

+7.4% YoY

1,184.7

1,424.4

+20.2% YoY

GROSS PROFIT

640.2

824.3

+28.8% YoY

OPERATING PROFIT

533.8

663.8

+24.4% YoY

NPAT

16

949(56%)

1,156(63%)

212(27%)

239(29%)

24(27%)

29(29%)

2017 2018

1,690(66%)

1,844(67%)

795(31%)

820(30%)

89(3%)

100(4%)

2017 2018

All business segment grew compared to last year withmargin improvement

Herbal Medicine Food & Beverages Pharmaceutical

%Growth

+9.1%

+3.1%

+13.2%

2,5742,763

SALES(%Proportional)

+7.4%

1,185(46%)

1,424(52%)+20.2%

Gross Profit(%Gross Profit Margin)

+21.8%

+12.7%

+24.0%

%Growth

(Rp Billion – Audited)

17

197 176

345

242

2015 2016 2017 2018

25 2629

15

85% 82% 81% 77%

2015 2016 2017 Nov-18

Solid cash positions and high dividend payout ratio

(Rp Billion – 2015-2018 Audited)

CASH & CASH EQUIVALENTS

Payout Ratio

DIVIDEND PER SHARE

CAPEX

1,027 1,002903

806

2015 2016 2017 2018

*Interim Dividend

APPENDIX

19

SIDO structure

PT INDUSTRI JAMU DAN FARMASISIDO MUNCUL TBK

PT HOTEL CANDI BARU(81.0%)

*PUBLIC(19.0%)

MunculMekar SHI Berlico Muncul

Nigeria

99.99% 99.99% 99.99% 99.99%

*SIDO owns 0.8% from share buyback program

PT Muncul Mekar

The commencement ofoperation:

1987

Business activities:Trading

PT Semarang Herbal IndoPlant

The commencement ofoperation:

2009

Business activities:Herbal Extraction

PT Berlico Mulia Farma

The commencement ofoperation:

1993

Business activities:Pharmaceutical

Muncul Nigeria Limited

The commencement ofoperation:

2018

Business activities:Trading

20

Profit Or Loss – Audited FY 2018

Rp Billion - Audited 2018 2017 ∆ %gr.SALES 2,763.3 2,573.8 189.5 7.4%COST OF GOODS SOLD (1,338.9) (1,389.1) 50.2 -3.6%GROSS PROFIT 1,424.4 1,184.7 239.7 20.2%%Margin 51.5% 46.0% 5.5%

Selling & Marketing Expenses (414.0) (364.2) (49.8) 13.7%General & Administrative Expenses (202.7) (194.8) (7.9) 4.1%Other Operational Expenses (Income) 16.7 14.5 2.2 15.2%OPERATING PROFIT 824.3 640.2 184.1 28.8%%Margin 29.8% 24.9% 5.0%

Finance Income 43.6 42.2 1.4 3.3%Finance Cost (0.1) (0.6) 0.4 -76.0%PROFIT BEFORE INCOME TAX EXPENSES 867.8 681.9 185.9 27.3%%Margin 31.4% 26.5% 4.9%

Income Tax Expense - Net (204.0) (148.1) (55.9) 37.7%PROFIT FOR THE YEAR 663.8 533.8 130.1 24.4%%Margin 24.0% 20.7% 3.3%

21

This presentation is made to provide information. No representation or warranty is made as to thefairness, accuracy, completeness or correctness of the information, opinions and conclusionscontained within this presentation. All information including business forward plans in thispresentation should not be considered as a recommendation in relation to holding purchasing orselling shares in any jurisdiction. No copy or use of this presentation should occur without thepermission of PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK.

Disclaimer

22

PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

HEAD OFFICE:Gedung Menara Suara Merdeka, Lt. 16Jalan Pandanaran No. 30Semarang - Indonesia

BRANCH OFFICE:Grha Muncul MekarJl. Panjang Arteri Kelapa Dua, No. 27Kebon JerukJakarta Barat - Indonesia

EMAIL:investor.relation@sidomuncul.co.id